Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Vera Evtimov"'
Autor:
Runzhe Shu, Maree Hammett, Vera Evtimov, Aleta Pupovac, Nhu‐Y Nguyen, Rasa Islam, Junli Zhuang, Seyeong Lee, Tae‐hun Kang, Kyujun Lee, Ian Nisbet, Peter Hudson, Jae Young Lee, Richard Boyd, Alan Trounson
Publikováno v:
Bioengineering & Translational Medicine, Vol 8, Iss 6, Pp n/a-n/a (2023)
Abstract Manufacture of chimeric antigen receptor (CAR)‐T cells usually involves the use of viral delivery systems to achieve high transgene expression. However, it can be costly and may result in random integration of the CAR into the genome, crea
Externí odkaz:
https://doaj.org/article/45ebc5081db64747a278f36cfaca95ba
Autor:
Nicholas Boyd, Kellie Cartledge, Huimin Cao, Vera Evtimov, Aleta Pupovac, Alan Trounson, Richard Boyd
Publikováno v:
Cells, Vol 10, Iss 10, p 2631 (2021)
Cellular immunotherapy is revolutionizing cancer treatment. However, autologous transplants are complex, costly, and limited by the number and quality of T cells that can be isolated from and expanded for re-infusion into each patient. This paper dem
Externí odkaz:
https://doaj.org/article/034b396e53284c879473881ba8f7df8e
Autor:
Rasa Islam, Aleta Pupovac, Vera Evtimov, Nicholas Boyd, Runzhe Shu, Richard Boyd, Alan Trounson
Publikováno v:
Cells, Vol 10, Iss 5, p 1058 (2021)
Natural killer (NK) cells are potent innate immune system effector lymphocytes armed with multiple mechanisms for killing cancer cells. Given the dynamic roles of NK cells in tumor surveillance, they are fast becoming a next-generation tool for adopt
Externí odkaz:
https://doaj.org/article/5a61333ee57a4ba3aecd62fcdb92a25b
Autor:
Richard L. Boyd, Nicholas Boyd, Vera Evtimov, Aleta Pupovac, Kellie Cartledge, Alan O Trounson, Huimin Cao
Publikováno v:
Cells
Volume 10
Issue 10
Cells, Vol 10, Iss 2631, p 2631 (2021)
Volume 10
Issue 10
Cells, Vol 10, Iss 2631, p 2631 (2021)
Cellular immunotherapy is revolutionizing cancer treatment. However, autologous transplants are complex, costly, and limited by the number and quality of T cells that can be isolated from and expanded for re-infusion into each patient. This paper dem
Autor:
Richard L. Boyd, Aleta Pupovac, Nicholas Boyd, Rasa Islam, Alan O Trounson, Vera Evtimov, Runzhe Shu
Publikováno v:
Cells, Vol 10, Iss 1058, p 1058 (2021)
Cells
Cells
Natural killer (NK) cells are potent innate immune system effector lymphocytes armed with multiple mechanisms for killing cancer cells. Given the dynamic roles of NK cells in tumor surveillance, they are fast becoming a next-generation tool for adopt
Autor:
Maureen C. Howard, Alan O Trounson, Runzhe Shu, Vera Evtimov, Aleta Pupovac, Maree V. Hammett, Junli Zhuang, Nhu-Y N. Nguyen, Peter John Hudson, Richard L. Boyd
Publikováno v:
Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 20, Iss, Pp 325-341 (2021)
Molecular Therapy: Oncolytics, Vol 20, Iss, Pp 325-341 (2021)
Chimeric antigen receptor (CAR) T cells have revolutionized blood cancer immunotherapy; however, their efficacy against solid tumors has been limited. A common mechanism of tumor escape from single target therapies is downregulation or mutational los
Autor:
K. Cartledge, R. Shu, M. Cao, M. Tiedemann, Alan O Trounson, Ian Nisbet, N. Nguyen, T. Nguyen, Vera Evtimov, Richard L. Boyd, Nicholas Boyd
Publikováno v:
Cytotherapy. 22:S199
Background & Aim The clinical impact of Chimeric Antigen Receptor T cell (CAR-T) technologies on hematological malignancies have revolutionized cancer treatment. However, current autologous CAR-T therapies face major roadblocks for mass adoption. The
Autor:
Natalie Thomas, Vera Evtimov
Publikováno v:
Encyclopedia of Cancer ISBN: 9783642278419
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb132df78891d1387bcda52de894fec8
https://doi.org/10.1007/978-3-662-46875-3_2878
https://doi.org/10.1007/978-3-662-46875-3_2878